Navigation Links
How do neural stem cells decide what to be -- and when?
Date:11/15/2010

SINGAPORE Researchers at Duke-NUS Graduate Medical School in Singapore have uncovered a novel feedback mechanism that controls the delicate balance of brain stem cells.

Zif, a newly discovered protein, controls whether brain stem cells renew themselves as stem cells or differentiate into a dedicated type of neuron (nerve cell).

In preclinical studies, the researchers showed that Zif is important for inhibiting overgrowth of neural stem cells in fruit flies (genus Drosophila) by ensuring that a proliferation factor (known as aPKC) maintains appropriate levels in neural stem cells.

"There is a Zif-related protein in humans, and its function remains to be analyzed," said senior and corresponding author Hongyan Wang, Ph.D. "Our finding has paved the way for future study of this human protein in the context of diseases, including glioblastomas, the most severe form of brain tumors."

She said it may be "possible to manipulate Zif function into a form of therapy against diseases, including cancer."

The study was published in the Nov. 16 issue of Developmental Cell journal.

The findings suggest that a lack of Zif protein expression correlates with neural stem cell overpopulation in Drosophila.

The mechanism is circular: Zif is a transcription factor that inhibits the manufacture of aPKC. But Zif can also be tagged with a phosphate by aPKC, which excludes Zif from the cell nucleus, and leads to Zif inactivation, which in turn means an overgrowth of stem cells.

"Next, we would like to investigate the mechanisms of neural stem cells' self-renewal in mammals, and we are looking for the right collaborators," Wang said. "We will also continue to use Drosophila as a powerful model system to uncover critical players in neural stem cell self-renewal so that we can understand the network involved in this regulation."


'/>"/>

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

Page: 1

Related medicine news :

1. Neuralstem updates ALS clinical trial progress
2. Neuralstem chief scientific officer to take part in World Stem Cell Summit plenary session
3. Neuralstem stem cells survive and differentiate into neurons in rats with stroke
4. Misfolded neural proteins linked to autism disorders
5. The neural basis of the depressive self
6. Hurts so good -- neural clues to the calming effects of self-harm
7. Neuralstem files FDA application for first chronic spinal cord injury stem cell trial
8. Human neural stem cells restore motor function in mice with chronic spinal cord injury
9. FDA approves first human neural stem cell clinical trial to treat brain tumors
10. Neuralstem updates clinical trial progress
11. Race and empathy matter on neural level
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... IDC-Eating Disorder Care ... for the treatment program located in Royal Oak, Michigan. IDC, formerly known ... are focused on providing the highest standards in the field of eating disorder treatment ...
(Date:7/26/2017)... WI (PRWEB) , ... July 26, 2017 , ... The ... 2030 in the United States, but ways to improve asthma control in the population ... Clinical Immunology: In Practice (JACI: In Practice), an official journal of the American Academy ...
(Date:7/25/2017)... ... 25, 2017 , ... SureVest Insurance Group, a locally managed ... North Carolina, is launching a charity event in conjunction with the Triangle Chapter ... fight against bladder cancer. , The Bladder Cancer Advocacy Network (BCAN) operates multiple ...
(Date:7/25/2017)... Jacksonville, Fla. (PRWEB) , ... July 25, 2017 , ... ... employee and father Ezra Clark is taking advantage of a new benefit for employees ... “It really means a lot that the company supports me and other employees as ...
(Date:7/24/2017)... ... July 24, 2017 , ... Cheerag D. Upadhyaya , M.D., ... Bloch Neuroscience Institute (SLMBNI), part of Saint Luke’s Health System . Dr. ... Cheerag D. Upadhyaya, MD. M.Sc., FAANS joins Stanley P. Fisher, M.D., who ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... and EDMONTON, Alberta , July ... and the University of Alberta in ... in Nature,s partner journal, Schizophrenia 1 , demonstrating ... instances of schizophrenia with 74% accuracy. This retrospective ... of specific symptoms in schizophrenia patients with significant ...
(Date:7/21/2017)... know that PhRMA member companies invested $65.5 billion in research and ... generics and the supply chain account for 14 percent of total ... (7 percent)? Or that the United States ... high-growth biopharmaceutical startups? ... The biopharmaceutical industry accounts for 1 ...
(Date:7/17/2017)... , July 17, 2017  MedX Holdings, Inc., the ... testing, strengthening and rehabilitation equipment, today announced the national ... MedX is considered the gold standard for the treatment ... specialized medical strengthening equipment. ... with the physician or practice who prescribe the MedX ...
Breaking Medicine Technology: